Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Accenture
Boehringer Ingelheim
Express Scripts
Deloitte
Covington

Generated: August 21, 2019

DrugPatentWatch Database Preview

Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2018)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2018)

Docket   Try a Free Trial Date Filed 2018-01-09
Court District Court, D. New Jersey Date Terminated
Cause 15:1126 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Douglas E. Arpert
Parties CILAG GMBH INTERNATIONAL; JANSSEN PHARMACEUTICA NV; JANSSEN PHARMACEUTICALS, INC.; JANSSEN RESEARCH AND DEVELOPMENT LLC; LUPIN LIMITED; LUPIN PHARMACEUTICALS, INC.; MITSUBISHI TANABE PHARMA CORPORATION
Patents 6,414,126; 6,515,117; 7,943,582; 8,513,202
Attorneys AMY DANIELLE LURIA; CHARLES MICHAEL LIZZA; COLLEEN TRACY JAMES; DAVID LEIGH MOSES; WILLIAM C. BATON
Firms Critchley Kinum & Denoia LLC; Quinn Emanuel Urquhart & Sullivan, LLP; Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED

Details for MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 JP) 6,414,126 B1 7/2002 Ellsworth et a1. …characteristics, is characterized by its 6,414,126 B1 7/2002 Ellsworth et al. …United States Patent Nos. 7,943,582 (the “’582 patent”) and 8,513,202 (the “’202 patent”) (collectively… claim of the ’582 patent or ’202 patent other than for claim 7 of the ’582 patent and claim 4 of the… claim of the ’582 patent or ’202 patent other than for claim 7 of the ’582 patent and claim 4 of the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Covington
Accenture
Johnson and Johnson
Fish and Richardson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.